Flagship Pioneering introduced the latest company, Mirai Bio, during the BioProcess International Conference in Boston.

MED6-189 targets and disrupts the parasite’s apicoplast and also vesicular trafficking pathways, a dual mode of action that ...

The developers of the model claim it is the first developed specifically to identify drugs for rare diseases and conditions ...

Cleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut. The findings pave the way for potential new treatments for a variety of inflammatory and ...

As Congress wrangles over a budget for the 2025 federal fiscal year, which begins October 1, the NIH will be paying especially close attention. Last year, the NIH saw its first year-over-year funding ...

Researchers suggest the DeepRVAT model is the first to use artificial intelligence (AI) in genomic association studies to decipher rare genetic variants.